focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities

7 Apr 2021 17:51

RNS Number : 7425U
Oilex Ltd
07 April 2021
 

ASX-AIM Announcement

 

 

7 April 2021

 

ASX: OEX

AIM: OEX

 

Re: Issue of Securities

 

Oilex Ltd (Oilex or the Company) advises that it has issued 234,348,086 new ordinary shares pursuant to the exercise of unlisted options for conversion proceeds of £265,125. The options exercised comprise:

· 204,545,455 new ordinary shares on the conversion of 204,545,455 options at £0.0011 pursuant to the Series D loan. The issue of this options class was approved by shareholders on 30 June 2020. There are no remaining options on issue in this class.

· 14,802,631 new ordinary shares on the conversion of 14,802,631 options at £0.0019. The issue of this options class was approved by shareholders on 27 November 2019 and 30 June 2020. There are no remaining options on issue in the class.

· 15,000,000 new ordinary shares on the conversion of 15,000,000 options at £0.0008. There are no remaining options on issue in the class.

The proceeds of the unlisted options will be applied to the repayment of the Series D Loan and the Company's working capital requirements.

 

Pursuant to conversion of the options, the Company has issued 234,348,086 shares under Listing Rule 7.2 Exception 9.

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of the 234,348,086 new shares (Shares) to trading on AIM (Admission). Admission of the Shares is expected to become effective and dealings to commence at 8.00 a.m. on 13 April 2021. Following Admission of these shares, the Company will have 4,655,766,968 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 4,655,766,968.

 

 

Section 708A(5)(e) Statement

 

Pursuant to the issue of the 234,348,086 shares, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.

 

 

For and on behalf of Oilex Ltd

 

 

Mark Bolton

Executive Director and Company Secretary

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAKLXELKFEFA
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.